Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$764K Hold
2,110
0.17% 60
2026
Q1
$742K Hold
2,110
0.27% 55
2025
Q4
$691K Sell
2,110
-600
-22% -$190K 0.25% 60
2025
Q3
$765K Hold
2,710
0.23% 74
2025
Q2
$757K Hold
2,710
0.27% 67
2025
Q1
$844K Buy
2,710
+900
+50% +$266K 0.36% 51
2024
Q4
$472K Buy
1,810
+357
+25% +$106K 0.3% 68
2024
Q3
$468K Buy
1,453
+53
+4% +$17.3K 0.21% 58
2024
Q2
$437K Hold
1,400
0.21% 54
2024
Q1
$398K Hold
1,400
0.2% 61
2023
Q4
$403K Hold
1,400
0.22% 54
2023
Q3
$376K Hold
1,400
0.22% 53
2023
Q2
$311K Hold
1,400
0.17% 69
2023
Q1
$338K Hold
1,400
0.2% 59
2022
Q4
$368K Hold
1,400
0.22% 51
2022
Q3
$316K Buy
+1,400
New +$339K 0.2% 54

Other funds holding AMGN

Alta Advisers's AMGN Position: Q2 2026 in Review

Alta Advisers held its Amgen (AMGN) position steady in Q2 2026 at 2,110 shares worth $764K. The position accounts for 0.17% of the portfolio, ranked #60.

Alta Advisers first reported a position in AMGN in Q3 2022 and has held it in 16 quarters since. The position peaked at $844K in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Alta Advisers held 2,110 shares of Amgen worth $764K as of Q2 2026.
  • Alta Advisers left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.17% of Alta Advisers's portfolio in Q2 2026, its #60 holding.
  • Alta Advisers first reported a position in Amgen in Q3 2022 and has held it in 16 quarters since.
  • Alta Advisers's Amgen position peaked at $844K in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Alta Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.